Cardiopulmonary bypass reduces pulmonary surfactant activity in infants

Journal of Thoracic and Cardiovascular Surgery

Volumn 118, Issue 2, 1999, Pages 237-244

  Griese, M ^a   Wilnhammer, C ^a   Jansen, S ^a   Rinker, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; LUNG SURFACTANT; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; SPHINGOMYELIN;

ARTICLE; BYPASS SURGERY; CARDIOPULMONARY BYPASS; CHILD; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; KALLIKREIN KININ SYSTEM; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS SURFACE TENSION; LUNG CAPILLARY; LUNG INJURY; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; NEWBORN; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE ACTIVATION; TRACHEOBRONCHIAL TREE;

EID: 0032787704     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(99)70213-8     Document Type: Article

References (27)

1. PD Macnaughton S Braude DN Hunter Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass Crit Care Med 20 1992 1289 1294
2. K Tanaka K Kumon F Yamamoto Respiratory care of pediatric patients requiring prolonged intubation after cardiac surgery Crit Care Med 14 1986 617 619
3. S Westaby Organ dysfunction after cardiopulmonary bypass: a systemic inflammatory reaction initiated by the extracorporeal circuit Intens Care Med 13 1987 89 95
4. SD Tennenberg CW Clardy WW Bailey Complement activation and lung permeability during cardiopulmonary bypass Ann Thorac Surg 50 1990 597 601
5. H Komani SG Haworth The effect of cardiopulmonary bypass on the lung I Jonas M Elliot Cardiopulmonary bypass in neonates, infants and young children 1994 Butterworth-Heinemann Oxford 242 262
6. M Elliott AR Finn Interaction between neutrophils and endothelium Ann Thorac Surg 56 1993 1503 1508
7. NE Moat DF Shore TW Evans Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins Eur J Cardiothoracic Surg 7 1993 563 573
8. BA Holm Surfactant inactivation in adult respiratory distress syndrom B Robertson L van Golde JJ Batenburg Pulmonary surfactant: from molecular biology to clinical practice 1992 Elsevier Amsterdam 665 684
9. DD Walters The role of pulmonary surfactant in transepithelial movement of liquid B Robertson L van Golde JJ Batenburg Pulmonary surfactant: from molecular biology to clinical practice 1992 Elsevier Amsterdam 193 213
10. JF Lewis AH Jobe Surfactant and the adult respiratory distress syndrome Am Rev Respir Dis 147 1993 218 233
11. M Heikinheimo M Hynynen P Rautiainen S Andersson Successful treatment of ARDS with two doses of synthetic surfactant Chest 105 1994 1263 1264
12. TJ Gregory KP Steinberg R Spragg JE Gadek Bovine surfactant therapy for patients with acute respiratory distress syndrome Am J Respir Crit Care Med 155 1997 1309 1315
13. D Walmrath A Günther HA Ghofrani Bronchoscopic surfactant administration in patients with severe adult respiratory distress syndrome and sepsis Am J Respir Crit Care Med 154 1996 54 62
14. M Griese P Dietrich D Reinhardt Pharmocokinetics of bovine surfactant in neonatal respiratory distress syndrome Am J Respir Crit Care Med 152 1995 1050 1054
15. NJ Gross RM Schultz Serine protease requirement for the extracellular metabolism of pulmonary surfactant Biochim Biophys Acta 1044 1990 222 230
16. RW Veldhuizen K Inchley SA Hearn JF Lewis JF Possmayer Degradation of surfactant-associated protein B (SP-B) during in vitro conversion of large to small surfactant aggregates Biochem J 1993 141 147
17. M Griese P Dietrich C Potz B Westerburg R Bals D Reinhardt Surfactant subfractions during nosocomial infection in ventilated preterm human neonates Am J Respir Crit Care Med 153 1996 398 403
18. M Griese P Birrer A Demirsoy Pulmonary surfactant in cystic fibrosis Eur Respir J 10 1997 1983 1988
19. H Motulsky Intuitive biostatistics 1995 Oxford University Press New York
20. M Shah H Najafi C Serry R Callaghan J Yang Pathophysiological alterations in perfused and non-perfused lungs during cardiopulmonary bypass Ann Thorac Surg 10 1970 402 408
21. S Marcatili C Guarino A Giannattasio Alterations of the endoalveolar surfactant after surgery with extracorporeal circulation Respiration 57 1990 233 238
22. FX McGowan M Ikegami PJ del Nido EK Motoyama G Kurland PJ Davis Cardiopulmonary bypass significantly reduces surfactant activity in children J Thorac Cardiovasc Surg 106 1993 968 977
23. TE Nicholas JT Power HA Barr The pulmonary consequences of a deep breath Respir Physiol 49 1982 315 324
24. RJ Mason Surfactant secretion B Robertson LG van Golde JJ Batenburg Pulmonary surfactant: from molecular biology to clinical practice 1992 Elsevier Amsterdam 295 312
25. W Seeger C Grube A Günther R Schmidt Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations Eur Respir J 6 1993 971 977
26. PD Macnaughton TW Evans The effect of exogenous surfactant therapy on lung function following cardiopulmonary bypass Chest 105 1994 421 425
27. J DoCampo EG Bertranou A De Lorenzi AA Hager Nebulised exogenous natural surfactant after cardiac surgery Lancet 343 1994 482